February 2026

FDA approves next-generation CardioMEMS reader for heart failure monitoring ()
GLP-1 drugs and healthy habits work together to boost heart health, Harvard study confirms ()
AI helps identify risk in adults with congenital heart disease ()
New heart device for ‘no-option’ chest pain patients shows early potential ()
Radiation doses during heart scans vary dramatically from one country to the next ()
Whole-body MRI provider starts offering AI-powered CCTA scans ()
Vascular imaging at heart of $71M fraud scheme—DOJ announces prison sentences ()
3D software helps cardiologists plan ahead for TAVR complications ()
FDA clears AI-powered platform that personalizes care during TAVR, cardiac pacing procedures ()
PFO closure after thromboembolism linked to strong 20-year outcomes ()
Excessive alcohol use increases risk of amputation in CLTI patients ()
FDA shares new warning about Johnson & Johnson heart pumps after 4 injuries ()
Women of all ages face rising risks of heart disease and stroke—but cardiologists see a path forward ()
Medtronic’s diabetes division seeks $7.9B valuation in upcoming IPO ()
How the rise of AI could lead to efficiency issues and lower reimbursement payments ()
AHA launches women’s health initiative—doctor Jen Ashton and husband donate $1M ()
Weight-loss surgery protects the heart more than GLP-1 drugs ()
It’s about to get harder for many Medicare patients to see a cardiologist ()
TAVR a safe treatment option for patients who have undergone chest radiation therapy ()
ASE promoting 3D echo as a better way to treat congenital heart disease ()
FDA approves new Biotronik pacing lead for LBBAP ()
Registry data point to ‘striking shift’ in treatment decisions after FDA approved low-risk TAVR ()
Death after PCI seen in just 0.5% of patients—heart attack, cardiac arrest most common causes ()
New study of homozygous familial hypercholesterolemia finds higher LDL-C levels in women ()
Cardiologist says new legislation would delay flawed payment cuts, preserve access to care ()
First ACC/AHA acute pulmonary embolism guidelines include new categories for risk stratification ()
Heart failure company BioVentrix files for IPO ()
Gore completes acquisition of medtech company behind next-gen heart device ()
Medtronic’s RDN system receives new reimbursement approval ()
Statin labeling should be revised with updated warnings, meta-analysis confirms ()
Esperion settles another lawsuit to keep generic versions of popular drug off shelves ()
Cardiologist develops new heart device that uses gel to reduce stroke risk in AFib patients ()
PAD patients could be missing out on recommended care following major lower extremity amputations ()
How hypertension during pregnancy impacts a woman's long-term cardiovascular health ()
Cardiology, cardiac imaging groups support new bill delaying cuts to physician pay ()
AI-powered MRI evaluations predict STEMI outcomes better than existing risk scores ()
Medtronic reports rising sales for cardiovascular devices—PFA tech leads the way ()
TAVR linked to higher reintervention rate than SAVR in Evolut Low Risk trial update ()
FDA clears 12-lead, cable-free home ECG monitoring system ()
Universal heart screening for all athletes? Not so fast, cardiologists warn ()
Childhood obesity linked to significant vascular damage, long-term risks ()
CVRx highlights revenue growth in Q4, increased momentum going forward ()
CCTA becoming an essential tool for interventional cardiologists ()
Cardiologists propose new 'coronary risk zone' approach for redo TAVR planning ()
Cardiac imaging registry expands to include former NBA, NHL players ()
CCTA delivers value, even when treating low-risk patients with no history of CAD ()
MRI scans evaluate heart failure risk—no invasive catheterization required ()
Ultrathin iron bioresorbable scaffold shows promise in first randomized trial ()
Cardiologist discusses Lp(a), the CVD risk factor responsible for many surprise heart attacks ()
Edwards celebrates double-digit TAVR sales growth in Q4 ()
Billionaire donates $50M to advance cardiovascular care at Northwestern ()
New heart catheter for cell therapy delivery 1 step closer to FDA approval ()
Blood glucose monitor instructions updated due to error code linked to 114 injuries ()
Stroke risk after TAVR still higher for woman as ‘sex paradox’ lives on ()
Reprocessed EP catheters recalled due to contamination risk ()
New initiative to fund pulmonary embolism research ()
ECG market keeps evolving thanks to AI, home monitoring and Epic integration ()
Safety update: New recommendations for managing patients with high-risk defibrillation leads ()
Impella use fails to improve mortality in elderly patients ()
Boston EP Party: Medtech companies share new electrophysiology data at AF Symposium 2026 ()
TAVR valve for AR , a recent Edwards acquisition, delivers long-term value ()
Cardiologist impressed by experimental pill that significantly lowers cholesterol ()
Cardiologists urge Congress to pass new bills focused on PAD, Medicare coverage ()
FDA announces recall of Johnson & Johnson devices after multiple injuries, 1 death ()
New recall includes nearly 23K bottles of triglycerides drug used to treat heart disease ()
SAVR linked to ‘excellent’ long-term survival for patients with bicuspid aortic valves ()
New meta-analysis explores potential of endovascular treatments for long femoropopliteal lesions ()
Building a More Intelligent Cardiology Practice: IT Platforms, Human-led AI and Agentic Intelligence ()
Cardiologist sparks fresh debate over mandatory vaccines ()
FDA shares update about CGM sensor recalls—issue now linked to 860 serious injuries ()
2026 Best in KLAS rankings examine cardiovascular information systems, hemodynamic solutions ()
Medtronic SVP Nina Goodheart to retire after nearly 20 years in cardiovascular care ()
Key trends in transcatheter tricuspid valve repair and replacement ()
Interventional cardiologists take on angiography-derived physiology in new expert opinion ()
Pioneer heart surgeon Vinay Badhwar elected STS president ()
FDA warns that Johnson & Johnson heart pump sensors may malfunction—22 injuries reported ()
Medtronic to acquire AI-enabled FFR specialists CathWorks for up to $585M ()
Nasal spray for paroxysmal supraventricular tachycardia enters US market ()
Men developed CVD earlier than women, according to 35-year CARDIA study ()
Comparable long-term survival seen in two common CABG strategies ()